2,833 publications from this institution
In the first clinical trial of a machine learning algorithm for ventilation needs among COVID-19 patients, the algorithm demonstrated accurate prediction of the need for mechanical ventilation within 24 h. This algorithm may help care teams effectively triage patients and allocate resources. Further, the algorithm is capable of accurately identifying 16% more patients than a widely used scoring system while minimizing false positive results.
Some research has been done on connections between uses of oral ways and written means in helping relationships. In particular, becoming so involved in their writings, psychoanalysts publish clinical cases about ex-patients cures. Nevertheless, the effects of the reading of his case by the concerned ex-analysand are a topic on which very few data are available, except for Serge Doubrovsky’s example (1999).In this field, the question which is studied here is : what would be the effects on a former analysand, Jacques, of his readings of his case published in two documents (a book and an article) written by his ex-psychoanalyst. The situation is unusual because their comparison leads to assuming a sort of parapraxis by the author during the writing of that article because of the disappearance of an essential paragraph appearing in the book. This kind of lapse by the analyst would illustrate Dona Rudelic-Fernandez’s hypothesis (1994) according to which the study of a clinical may reveal inanalysed elements of the concerned cure.Thus, an unforeseen and unlikely device would have been set up, via some published writings or intended to be so. And the analysis of an analyst’s article by the former analysand would have contributed, besides other perlaborations, to his autonomisation with regard to his transfer on his former analyst.This hypothetical and provisional conclusion cannot be generalized. Like this, in Plato’s Pharmacy (1997), Jacques Derrida commenting on Plato’s Phaedra, notices that the writing may form either a narcotic or a medicine for the life of the memory.
SCOPUS: ed.j
We report a patient with Herpes Simplex Virus induced diffuse interstitial pneumonia associated with ARDS. A dramatic improvement in the respiratory function seems to have followed acyclovir administration.
Letters and Corrections1 June 1980Passive EuthanasiaJ. L. VINCENT, M.D.J. L. VINCENT, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-92-6-865_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In the January issue, Lo and Jonsen (1) exposed clearly the problems of euthanasia. The ethical questions, very well defined by them, are expressed in similar words everywhere in the world. In the intensive-care unit, the "right to die" can present somewhat different aspects when life is depending only on heavy technical support. Communication with these critically ill patients is almost always impossible, and the opinion of the family is generally inconsistent.When I served a 2-year fellowship in critical care in the United States, I was one of five foreign physicians (from Israel, France, Spain, Holland,...References1. LOJONSEN BA. Ethical decisions in the care of a patient terminally ill with metastatic cancer. Ann Intern Med. 1980;92:107-11. LinkGoogle Scholar2. RACHELS J. Active and passive euthanasia. N Engl J Med. 1975;292:78-80. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: University Hospital Erasme Free University of Brussels Brussels Belgium PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 June 1980Volume 92, Issue 6Page: 865-865KeywordsCritical careEuthanasiaFellowships Issue Published: 1 June 1980 PDF DownloadLoading ...
info:eu-repo/semantics/published
Statistics for 1984 show that 59% of people die in hospitals: 27% at home and 8% in homes for the aged. This article looks at the situation in a teaching hospital, the Erasmus University Hospital in Brussels. After a brief description of the associated clinics, tables list the contributions made by teaching hospitals to increased life expectancy in the population and principal cause of death statistics. It is suggested that increasingly the hospital will be confronted with terminal cases; a return home to die is often impossible. Even if the home could be adapted to allow for the terminal care of a relative often the family finds it difficult to cope with this idea and prefers hospital based terminal care for a relative.
SUMMARY Tumour necrosis factor‐α (TNF‐α) is well established as a key mediator in the inflammatory response seen in various disease processes including sepsis. TNF‐α is involved in virtually all features of septic shock and multiple organ failure. Anti‐TNF‐α strategies are thus appealing and have been effective at reducing inflammation and morbidity in certain conditions including rheumatoid arthritis and Crohn's disease. Afelimomab is the F(ab') 2 fragment of a murine anti‐TNF‐α antibody, and has been evaluated in clinical trials in septic patients. The results suggest that the drug is well tolerated, and may be of benefit in certain groups of patients with sepsis. A large, randomised, clinical trial of afelimomab in patients with severe sepsis has recently been completed and the results are eagerly awaited. More work is necessary to identify a means of selecting which patients are most likely to benefit from this type of therapy in sepsis. ( Int J Clin Pract 2000; 54(3) : 190‐193)
